Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Genes, Genetics and Genealogy: Three Roadmaps for CMT
…Accelerate Research (STAR). Could our genealogy tell us even more? My mother had researched genealogy for her and my father’s families for years, but she wasn’t looking for hereditary diseases….
The 2021 CMTA Annual Report
…our community outreach efforts invigorate and inform our research efforts, with the community providing the energy, excitement and funding for the research. You’ll read about all of it in the…
CMTA Announces Its First Center of Excellence in Scotland
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Katie Brennan, MD, PhD, at Queen Elizabeth University Hospital…
Hereditary Sensory Neuropathy (HSN)
…the DNMT1 gene. HSN1F HSN1F is due to the gene ATL3 on chromosome 11q12.3-q13.1. HSN Research Hereditary Sensory Neuropathy Serine trial (SENSE trial) See what’s happening in HSN research ⟶…
Stanford Chronic Pain Study
Stanford Chronic Pain Study A Stanford research team needs feedback from patient advisors to make their five-year study welcoming for all patients living with chronic pain. They are gathering a…
CMTA and Addex Announce CMT1A Collaboration
…of key outcomes. These outcome measures include biomarkers, motor function, electrophysiology and peripheral nerve histology. This is made possible through the CMTA’s preclinical testing alliance: www.cmtausa.org/our-research/for-researchers/cmta-preclinical-testing-network/ Download the full release…
The Fall 2020 CMTA Report
…issue is available now and full of information for you. Inside, we bring you coverage of CMT research projects with a special focus on CMT1A, stories and perspectives from people…
Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Charcot-Marie-Tooth Disease
…and Chief Executive Officer of Acceleron. “We wish to thank all of the patients, families, caregivers, and investigators for their support and participation in this research. I also want to…
CMTA Funds Cutting-Edge Gene Editing Studies for Type 2 CMT
…technologies shows the remarkable progress in this field and the critical role that basic science research plays in the development of research tools and potential disease treatments. Editing the genomes…
The CMT&ME Study: What It’s Like to Live with CMT
There’s been little research to date into how CMT affects the lives of patients. The French company Pharnext, CMT scientific experts, and international patient advocacy organizations (PAOs) have therefore partnered…